Pfizer
May 22, 2012 at 14:33 | Source: CNBC-TV18
May 22, 2012 at 10:15 | Source: Moneycontrol.com
May 21, 2012 at 19:36 | Source: PTI
May 21, 2012 at 15:07 | Source: Moneycontrol.com
May 17, 2012 at 10:12 | Source: Reuters
May 17, 2012 at 07:16 | Source: Reuters
News across the web »
May 27, 2012 at 14:31 | Source: Economic Times
May 26, 2012 at 08:21 | Source: Forbes
May 25, 2012 at 00:01 | Source: Forbes
May 24, 2012 at 11:11 | Source: Forbes
May 24, 2012 at 00:26 | Source: Forbes
Interact & exchange stock tips & market info »
Related News »
In the fall of 2010, Pfizer trumpeted the purchase of a small, privately held drugmaker called FoldRx Pharmaceuticals, which developed its own discovery platform technology and was completing testing for it lead compound. The medication, which ...
May 23, 2012 at 17:17 | Source: Forbes
A Pfizer (PFE) (PFE) Inc. drug that has transformed treatment for adult lung cancers caused by a gene defect is now saving children with deadly tumors. Pfizer’s Xalkori eradicated signs of malignancy in some kids with rare tumors of the nerves ...
May 17, 2012 at 14:11 | Source: Businessweek
WASHINGTON – A Food and Drug Administration advisory panel said a clinical study submitted by Pfizer Inc. (PFE) for a drug to treat a rare genetic disorder that affects the nervous system contains enough information for the FDA to consider ...
May 24, 2012 at 21:05 | Source: FOXBusiness
(Reuters) - A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare neurodegenerative disease. The U.S. Food and Drug Administration panel voted 13 to 4 that the drug did not show that it met the main goal ...
May 25, 2012 at 04:36 | Source: YAHOO!
(RTTNews) - Pfizer Inc. (PFE: News ) announced Thursday that the United States Food and Drug Administration's or FDA Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine. Tafamidis ...
May 24, 2012 at 22:17 | Source: RTT News
The FINANCIAL -- Pfizer named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012. According to Pfizer Inc., he will succeed David Simmons, who is leaving Pfizer to ...
May 25, 2012 at 10:13 | Source: The FINANCIAL
May 25, 2012 (Close-Up Media via COMTEX News Network) -- Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Pfizer's oncology leadership team at an analyst and investor meeting on Sunday, June 3, at 6 ...
May 25, 2012 at 04:51 | Source: comcast.net
Pfizer's Q4FY12 results were below our expectations. The company reported 17%YoY sales growth against 15% for the industry. The results of the two quarters are not comparable as the previous quarter of 4m period ended 31st March'11. Pfizer's EBIDTA margin ...
May 25, 2012 at 15:13 | Source: equitybulls.com
Pfizer Inc. (NYSE: PFE) named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012. He will succeed David Simmons, who is leaving Pfizer to become the ...
May 23, 2012 at 15:16 | Source: Genetic Engineering News
(RTTNews.com) - Pfizer, Inc. (PFE) said the Committee for Human Medicinal Products, or CHMP, of the European Medicines Agency has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union for the ...
May 25, 2012 at 13:26 | Source: NASDAQ